BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17385676)

  • 1. Chemiluminescent determination of leukocyte alkaline phosphatase: an advantageous alternative to the cytochemical assay.
    Kanegae MP; Ximenes VF; Falcão RP; Colturato VA; de Mattos ER; Brunetti IL; da Fonseca LM
    J Clin Lab Anal; 2007; 21(2):91-6. PubMed ID: 17385676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte alkaline phosphatase (LAP) by flow cytometry.
    Eshel E; Sharabi-Nov A; Dally N
    MLO Med Lab Obs; 2013 Aug; 45(8):22, 24, 26. PubMed ID: 24205536
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
    Tsavaris NB; Pangalis GA
    Ann Hematol; 1998 Jan; 76(1):1-5. PubMed ID: 9486917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochemical alkaline phosphatase test of mature neutrophils in the different diagnosis of myeloproliferative disorders.
    BLUM LL
    J Indiana State Med Assoc; 1962 Dec; 55():1783-4. PubMed ID: 13971867
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential leucocyte alkaline phosphatase activity (LAPA) in chronic myeloid leukaemia (CML) and myeloid leukemoid reaction (MLR).
    Zafar MN; Navid-ul-Haq ; Qureshi SJ; Qureshi H
    J Pak Med Assoc; 1984 May; 34(5):114-6. PubMed ID: 6429381
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemiluminescence of neutrophils in patients with myeloproliferative or myelodysplastic hematologic diseases--relation to neutrophil alkaline phosphatase activity.
    Wakita H; Asai T; Oh H; Itoh K; Yoshida S
    Intern Med; 1993 Mar; 32(3):204-9. PubMed ID: 7687168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases.
    Aye le L; Loghavi S; Young KH; Siddiqi I; Yin CC; Routbort MJ; Liang M; Eilerman K; Medeiros LJ; Brynes RK; Bueso-Ramos C
    Ann Diagn Pathol; 2016 Apr; 21():53-8. PubMed ID: 27040932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of alkaline phosphatase activity in chronic myeloid leukemia cells: in vitro studies and speculative hypotheses.
    De Renzo A; Micera V; Vaglio S; Luciano L; Selleri C; Rotoli B
    Am J Hematol; 1990 Dec; 35(4):278-80. PubMed ID: 2239924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
    Rambaldi A; Terao M; Bettoni S; Bassan R; Battista R; Barbui T; Garattini E
    Blood; 1989 Apr; 73(5):1113-5. PubMed ID: 2930836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte alkaline phosphatase.
    Okun DB; Tanaka KR
    Am J Hematol; 1978; 4(3):293-9. PubMed ID: 362907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neutrophil alkaline phosphatase (NAP) activity in untreated myeloproliferative syndromes and in leukaemoid reactions.
    Bendix-Hansen K; Bergmann OJ
    Scand J Haematol; 1985 Aug; 35(2):219-24. PubMed ID: 4048868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of clonality in chronic neutrophilic leukaemia.
    Böhm J; Kock S; Schaefer HE; Fisch P
    J Clin Pathol; 2003 Apr; 56(4):292-5. PubMed ID: 12663642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
    Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
    Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic discrimination and cost effective assay strategy for leukocyte alkaline phosphatase.
    DePalma L; Delgado P; Werner M
    Clin Chim Acta; 1996 Jan; 244(1):83-90. PubMed ID: 8919203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemiluminescent detection of alkaline phosphatase in PhastGel.
    Theodosiou NG; Chatot CL; Ziomek CA
    Biotechniques; 1992 Dec; 13(6):898-901. PubMed ID: 1476742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of selective cytochemical reaction to zinc in peripheral blood granulocytes].
    Gol'dberg ED; Bovt VD; Eshchenko VA
    Klin Lab Diagn; 1993; (3):25-7. PubMed ID: 8963532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neutrophil alkaline phosphatase score].
    Nakamura Y; Waga K; Mitani K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():785-8. PubMed ID: 15658450
    [No Abstract]   [Full Text] [Related]  

  • 20. [Case of acquired hemolytic anemia with leukemoid reaction with special reference to activity of neutrophil alkaline phosphatase].
    Suzuki A; Shibata A; Takahashi Y; Takase S; Yamada A
    Naika; 1966 Mar; 17(3):555-60. PubMed ID: 5960503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.